Injection Site Reactions: Users may experience redness, swelling, or irritation at the injection site
Semaglutide is FDA-Approved for safe and effective weight managementbacked by science, trusted by doctors, and proven to work
This approach requires patience but delivers more lasting benefits than crash diets or extreme measures
premenopausal women, older adults) Monitoring should be risk-based, not routine by default
This method bypasses the gastrointestinal tract entirely during the absorption phase, which is a crucial distinction from oral medications that must pass through the stomach and intestines before entering systemic circulation
Approval Duration and Continuation Criteria: Initial and continuation approval: 16 weeks (oral and injectable)